These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 25431084)

  • 1. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.
    Robroeks CM; van Berkel JJ; Jöbsis Q; van Schooten FJ; Dallinga JW; Wouters EF; Dompeling E
    Eur Respir J; 2013 Jul; 42(1):98-106. PubMed ID: 23645402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.
    Dallinga JW; Robroeks CM; van Berkel JJ; Moonen EJ; Godschalk RW; Jöbsis Q; Dompeling E; Wouters EF; van Schooten FJ
    Clin Exp Allergy; 2010 Jan; 40(1):68-76. PubMed ID: 19793086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
    Suzukawa M; Ohta K; Sugimoto M; Ohshima N; Kobayashi N; Tashimo H; Tanimoto Y; Itano J; Kimura G; Takata S; Nakano T; Yamashita T; Ikegame S; Hyodo K; Abe M; Chibana K; Kamide Y; Sasaki K; Hashimoto H
    Allergol Int; 2024 Oct; 73(4):524-531. PubMed ID: 38658257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
    Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
    Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between exhaled inflammatory markers and asthma control in children.
    Van Vliet D; Smolinska A; Jöbsis Q; Rosias PP; Muris JW; Dallinga JW; van Schooten FJ; Dompeling E
    J Breath Res; 2016 Feb; 10(1):016014. PubMed ID: 26893372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled volatile organic compounds (VOCs) for prediction of asthma exacerbation in children.
    Gmachowska K; Podlecka D; Bonikowski R; Majak P; Kapka K; Jerzyńska J
    Int J Occup Med Environ Health; 2024 Sep; 37(3):351-359. PubMed ID: 39239929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electronic nose in the discrimination of patients with asthma and controls.
    Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.